Free Trial
NYSE:SENS

Senseonics (SENS) Stock Price, News & Analysis

$0.32
-0.03 (-8.51%)
(As of 09/6/2024 ET)
Today's Range
$0.32
$0.36
50-Day Range
$0.32
$0.49
52-Week Range
$0.32
$0.75
Volume
5.51 million shs
Average Volume
1.36 million shs
Market Capitalization
$172.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

Senseonics MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
520.2% Upside
$2.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.15mentions of Senseonics in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.13) to ($0.12) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.03 out of 5 stars

Medical Sector

764th out of 910 stocks

Process Control Instruments Industry

10th out of 13 stocks

SENS stock logo

About Senseonics Stock (NYSE:SENS)

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

SENS Stock Price History

SENS Stock News Headlines

Senseonics (NYSE:SENS) Receives New Coverage from Analysts at StockNews.com
Biden’s Capital Gains Tax to Devastate Savings!
Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.
Biden’s Capital Gains Tax to Devastate Savings!
Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.
Senseonics earnings preview: what Wall Street is expecting
See More Headlines
Receive SENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Senseonics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/08/2024
Today
9/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Process control instruments
Sub-Industry
Measuring And Control Equipment
Employees
90
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.00
High Stock Price Target
$2.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+520.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-60,390,000.00
Net Margins
-335.15%
Pretax Margin
-335.11%

Debt

Sales & Book Value

Annual Sales
$24.04 million
Book Value
$0.07 per share

Miscellaneous

Free Float
510,181,000
Market Cap
$171.21 million
Optionable
N/A
Beta
0.79
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Timothy T. Goodnow Ph.D. (Age 62)
    President, CEO & Director
    Comp: $1.34M
  • Dr. Mukul Jain (Age 51)
    Chief Operating Officer
    Comp: $767.65k
  • Mr. Kenneth L. Horton (Age 57)
    General Counsel & Corporate Development Advisor
    Comp: $702.33k
  • Dr. Francine Ratner Kaufman M.D. (Age 72)
    Chief Medical Officer & Director
  • Mr. Frederick T. Sullivan (Age 42)
    CFO, Secretary & Treasurer

SENS Stock Analysis - Frequently Asked Questions

How have SENS shares performed this year?

Senseonics' stock was trading at $0.5701 at the beginning of 2024. Since then, SENS shares have decreased by 43.4% and is now trading at $0.3225.
View the best growth stocks for 2024 here
.

How were Senseonics' earnings last quarter?

Senseonics Holdings, Inc. (NYSE:SENS) issued its quarterly earnings data on Thursday, August, 8th. The company reported ($0.03) earnings per share for the quarter, hitting the consensus estimate of ($0.03). The firm earned $4.87 million during the quarter, compared to analysts' expectations of $4.86 million. Senseonics had a negative net margin of 335.15% and a negative trailing twelve-month return on equity of 299.69%.

When did Senseonics IPO?

Senseonics (SENS) raised $45 million in an initial public offering on Friday, March 18th 2016. The company issued 15,800,000 shares at a price of $2.85 per share. Leerink Partners, Canaccord Genuity and Raymond James served as the underwriters for the IPO and BTIG was co-manager.

Who are Senseonics' major shareholders?

Senseonics' top institutional shareholders include Cubist Systematic Strategies LLC (0.08%). Insiders that own company stock include Mukul Jain, Douglas A Roeder, Sharon Larkin, Francine Kaufman, Edward Fiorentino, Anthony R Raab, Nick B Tressler, Timothy T Goodnow and Mirasol Panlilio.
View institutional ownership trends
.

How do I buy shares of Senseonics?

Shares of SENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:SENS) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners